Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter E. Boyd currently holds 284,024 shares of Aquestive Therapeutics, Inc. (AQST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter E. Boyd has been a net seller of AQST stock. They have purchased $13.5K and sold $336.9K worth of shares.
Peter E. Boyd's most recent insider trade was on Sep 9, 2026, when they sold 2,293 shares at $0.00 per share.
Peter E. Boyd serves as Executive at Aquestive Therapeutics, Inc. (AQST). They have executed 20 insider transactions totaling $350.4K over their tenure at the company.
Peter E. Boyd holds the position of Executive at Aquestive Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Peter E. Boyd has shown a selling trading pattern, with $13.5K in total purchases and $336.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Peter E. Boyd was on May 5, 2026, when they sold $237.3K worth of AQST shares. This transaction involved 56,778 shares at $4.18 per share.
Peter E. Boyd currently owns 284,024 shares of Aquestive Therapeutics, Inc. (AQST), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter E. Boyd's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter E. Boyd has 20 Form 4 filings on record as an insider at Aquestive Therapeutics, Inc..
Set alerts for Peter E. Boyd and 40,000+ other insiders.